5 Matching Annotations
  1. Last 7 days
  2. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen
    1
    1. scibot 26 Sep 2024
      RRID:SCR_024504

      DOI: 10.1158/2767-9764.CRC-24-0332

      Resource: WinNonlin (RRID:SCR_024504)

      Curator: @scibot

      SciCrunch record: RRID:SCR_024504

      What is this?
      RRID:SCR_024504
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11417675/
  3. Sep 2024
  4. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Phase 1 study of simlukafusp alfa (FAP-IL2v) with or without atezolizumab in Japanese patients with advanced solid tumors
    1
    1. scibot 12 Sep 2024
      RRID:SCR_024504

      DOI: 10.1158/2767-9764.CRC-24-0185

      Resource: WinNonlin (RRID:SCR_024504)

      Curator: @scibot

      SciCrunch record: RRID:SCR_024504

      What is this?
      RRID:SCR_024504
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11377867/
  5. Aug 2024
  6. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR)
    1
    1. scibot 18 Aug 2024
      RRID:SCR_024504

      DOI: 10.1016/j.xcrm.2024.101630

      Resource: WinNonlin (RRID:SCR_024504)

      Curator: @scibot

      SciCrunch record: RRID:SCR_024504

      What is this?
      RRID:SCR_024504
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11293336/
  7. May 2024
  8. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-line Treatment of KRAS-mutant Metastatic Colorectal Cancer: A Phase 1b Clinical Study
    1
    1. scibot 17 May 2024
      RRID:SCR_024504

      DOI: 10.1158/1078-0432.CCR-23-3053

      Resource: WinNonlin (RRID:SCR_024504)

      Curator: @scibot

      SciCrunch record: RRID:SCR_024504

      What is this?
      RRID:SCR_024504
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11094418/
  9. Apr 2024
  10. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    ADCT-602, a Novel PBD Dimer–containing Antibody–Drug Conjugate for Treating CD22-positive Hematologic Malignancies
    1
    1. scibot 13 Apr 2024
      RRID:SCR_024504

      DOI: 10.1158/1535-7163.MCT-23-0506

      Resource: SCR_024504

      Curator: @scibot

      SciCrunch record: RRID:SCR_024504

      What is this?
      RRID:SCR_024504
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10985467/